International Shooting Sport Federation
ISSF
News
Calendar
Competitions
Athletes
Academy
Inside ISSF
Rules
Media
Inside ISSF
Home
Inside ISSF
Anti-Doping
Information Portal on Doping - IPOD
Anti-Doping and Clean Sport
Therapeutic Use Exemption
Information Portal on Doping - IPOD
News
FAQ
ISSF Outreach Posters
Education and Awareness
WADA
2021 World Anti Doping Code
ADAMS
International Standards
2024 Prohibited List
2024 Summary
2024 Monitoring Program
IPOD Articles
Articles 2024
1.
2024 IPOD 2 Prohibited List 2025.pdf
2.
2024 IPOD 1 OG edition.pdf
Articles 2023
1.
2023 IPOD 5 2023 Year End Report.pdf
2.
2023 IPOD 4 Prohibited List.pdf
3.
2023 IPOD 3 Reminders about the risks associated with supplement use.pdf
4.
2023 IPOD 2 2022 Year End Report.pdf
5.
2023 IPOD 1st Edition 2023 ADEL Resources.pdf
Articles 2022
1.
2022 IPOD 6 WADA Prohibited List 2023.pdf
2.
2022 IPOD 5 Education on Privacy and Information Security Awareness.pdf
3.
2022 IPOD 4 Reminders about the risks associated with supplement use.pdf
4.
2022 IPOD 3 Webinar for athletes on the List and TUEs.pdf
5.
2022 IPOD 2 Key areas of athlete vulnerabilities to doping.pdf
6.
2022 IPOD 1 2021 Year End Report.pdf
Articles 2021
1.
2021 IPOD 3 2022 Prohibited List.pdf
2.
2021 IPOD 2 Important anti doping reminders before Tokyo OGs.pdf
3.
2021 IPOD 1 2020 Year End Report.pdf
Articles 2020
1.
2020 IPOD 3 2021 Prohibited List.pdf
2.
2020 IPOD 2 Notice on revised ISSF Anti Doping Rules coming into effect January 1 2021.pdf
3.
2020 IPOD 1 2019 Year End Report.pdf
Articles 2019
1.
2019 IPOD 6 2020 Prohibited List.pdf
2.
2019 IPOD 5 Reminders to Athletes on risks of taking supplements.pdf
3.
2019 IPOD 4 Reminders to Verify Medication.pdf
4.
2019 IPOD 3 Roles Responsibilities and Duties of all ISSF Athletes.pdf
5.
2019 IPOD 2 Therapeutic Use Exemptions.pdf
6.
2019 IPOD 1 Risks of supplement use and Inadvertent doping.pdf
Articles 2018
1.
2018 IPOD 6 Youth Olympic Games ISSF Focus Day.pdf
2.
2018 IPOD 5 Testing at the Changwon World Championships.pdf
3.
2018 IPOD 4 Focus on the WADA Athletes Committee.pdf
4.
2018 IPOD 3 ADEL the new Anti Doping E Learning Platform.pdf
5.
2018 IPOD 2 Monitoring Compliance to the ISSF Anti Doping Rules and the World Anti Doping Code.pdf
6.
2018 IPOD 1 2017 Anti Doping Report and Looking Ahead to 2018.pdf
Articles 2017
1.
2017 IPOD 6 The ISSF Anti Doping Committee and Code Compliance.pdf
2.
2017 IPOD 5 An Ongoing Debate.pdf
3.
2017 IPOD 4 Speaking Out on Doping.pdf
4.
2017 IPOD 3 ISSF Compliance with the World Anti Doping Code.pdf
5.
2017 IPOD 2 Test Your Anti Doping Knowledge.pdf
6.
2017 IPOD 1 2016 Anti Doping Report and Looking Ahead to 2017.pdf
Articles 2016
1.
2016 IPOD 6 Privacy Issues in Anti Doping.pdf
2.
2016 IPOD 4 Take the Anti Doping Quiz.pdf
3.
2016 IPOD 3 The IPOD answers questions on Meldonium and Jurisdiction over Athletes at the OGs.pdf
4.
2016 IPOD 2 Education and Awareness Successful Anti Doping Programs.pdf
5.
2016 IPOD 1 2015 Anti Doping Report and Looking ahead to 2016.pdf
Articles 2015
1.
2015 IPOD 6 Prohibited Association Explained.pdf
2.
2015 IPOD 5 Substantial Assistance Explained.pdf
3.
2015 IPOD 4 Interview with ISSF Athletes Committee Chairman Abhinav Bindra.pdf
4.
2015 IPOD 3 The WADA ADO Symposium Intelligence Based Testing The ISSF RTP.pdf
5.
2015 IPOD 2 The IPOD answers questions on Supplements Use and TUEs.pdf
6.
2015 IPOD 1 2014 Anti Doping Report and looking ahead to 2015.pdf
Articles 2014
1.
2014 IPOD 6 The 2015 ISSF Anti Doping Rules.pdf
2.
2014 IPOD 5 Therapeutic Use Exemptions Process.pdf
3.
2014 IPOD 4 A New and Revised World Anti Doping Code. Part III.pdf
4.
2014 IPOD 3 A New and Revised World Anti Doping Code. Part II.pdf
5.
2014 IPOD 2 A New and Revised World Anti Doping Code. Part I.pdf
6.
2014 IPOD 1 2013 Anti Doping Report.pdf
Articles 2013
1.
2013 IPOD 6 Looking head to 2014.pdf
2.
2013 IPOD 5 The IPOD answers 3 questions from its readers.pdf
3.
2013 IPOD 4 The IPOD answers 6 questions from its readers.pdf
4.
2013 IPOD 3 ISSFs Role in Anti Doping Education and Prevention.pdf
5.
2013 IPOD 2 WADA Accredited Laboratories for Doping Control Analysis.pdf
6.
2013 IPOD 1 2012 Anti Doping Report and looking ahead to 2013.pdf
Articles 2012
1.
2012 IPOD 5 2013 Prohibited List.pdf
2.
2012 IPOD 4 Anti Doping at the 2012 Summer Olympic Games in London.pdf
3.
2012 IPOD 3 Focus on Regional Anti Doping Organisations RADOs.pdf
4.
2012 IPOD 2 World Anti Doping Code review process and Risks of Supplements.pdf
5.
2012 IPOD 1 2011 Anti Doping Report.pdf
Articles 2011
1.
2011 IPOD 6 2012 Prohibited List.pdf
2.
2011 IPOD 5 Supplements Risks vs Rewards.pdf
3.
2011 IPOD 4 The IPOD answers 3 questions from its readers.pdf
4.
2011 IPOD 3 The IPOD answers 2 questions from its readers.pdf
5.
2011 IPOD 2 The IPOD answers 3 questions from its readers.pdf
6.
2011 IPOD 1 2010 Anti Doping Report.pdf
Articles 2010
1.
2010 IPOD 6 Looking ahead to ISSFs Anti Doping Initiatives for 2011.pdf
2.
2010 IPOD 5 Focus on the ISSF Medical Committee.pdf
3.
2010 IPOD 4 The Importance of Anti Doping Education.pdf
4.
2010 IPOD 3 Focus on WADA the World Anti Doping Agency.pdf
5.
2010 IPOD 2 The WADA Prohibited List.pdf
6.
2010 IPOD 1 2009 Anti Doping Report.pdf
Articles 2009
1.
2009 IPOD 6 The IOC Medical Commission and WADA.pdf
2.
2009 IPOD 5 Beware of Beta Blockers.pdf
3.
2009 IPOD 4 Abbreviated Therapeutic Use Exemptions.pdf
4.
2009 IPOD 3 Q A on Therapeutic Use Exemptions.pdf
5.
2009 IPOD 2 Q A on Prohibited Substances the IPOD quiz.pdf
